Comet assay as a human biomonitoring tool: application in occupational exposure to antineoplastic drugs
Antineoplastic drugs are a heterogeneous group of chemicals used in the treatment of cancer, and have been proved by IARC to be mutagens, carcinogens and teratogens agents (Fucic et al., 1998; Burgaz et al., 1999; Sessink & Bos, 1999; Bouraoui et al., 2011; Gulten et al., 2011; Buschini et al.,...
Main Authors: | Carina Ladeira, Susana Viegas, Manuel C. Gomes |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-05-01
|
Series: | Frontiers in Genetics |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/conf.fgene.2015.01.00019/full |
Similar Items
-
Relation between DNA damage measured by comet assay and OGG1 Ser326Cys polymorphism in antineoplastic drugs biomonitoring
by: Carina Ladeira, et al.
Published: (2015-09-01) -
Relation between DNA damage measured by comet assay and <em>OGG1 </em>Ser326Cys polymorphism in antineoplastic drugs biomonitoring
by: Carina Ladeira, et al.
Published: (2015-09-01) -
HBM4EU Chromates Study—Genotoxicity and Oxidative Stress Biomarkers in Workers Exposed to Hexavalent Chromium
by: Ana Tavares, et al.
Published: (2022-08-01) -
The Comet Assay as a Tool in Human Biomonitoring Studies of Environmental and Occupational Exposure to Chemicals—A Systematic Scoping Review
by: Carina Ladeira, et al.
Published: (2024-04-01) -
Correlation between the genotoxicity endpoints measured by two different genotoxicity assays: comet assay and CBMN assay
by: Carina Ladeira, et al.
Published: (2015-06-01)